June 2021

Take-away diagnostics: Delivering the future?

After a rise in at-home tests and a fall in non-COVID-related hospital attendances during the pandemic, will a new era of diagnostics be ushered in as we return to normality? We look at the evidence.

Unintended consequences

Computational biologist Gregorio Alanis- Lobato highlights the need for greater awareness of and further research into the effects of CRISPR-Cas9 genome editing.

The big question: multidisciplinary working

This month we ask: “What is the future of multidisciplinary working?”

The evolution of quality assessment

In 2011, UK NEQAS Cellular Pathology Technique (CPT) carried out tests across four schemes – it now covers 12 schemes with two in the pipeline. We hear from Chantell Hodgson, UK NEQAS CPT Scheme Manager.

Tech news: June

This month's top tech news stories

“Tumour-uninformed” blood test

A team of scientists has evaluated the first “tumour-uninformed” test that detects cancer DNA circulating in the blood of patients following treatment.

Ultrasonically oscillating biopsy needles

Modifying a biopsy needle to vibrate rapidly at 30,000 times per second improves yields and could mean potentially a less painful experience for patients.

My lab: The donor testing lab

Biomedical Scientist Kristopher Kelly gives a guided tour of the donor testing laboratory at the Scottish National Blood Transfusion Service.

Novel Covid test

A new rapid test has been developed that is 98.3% accurate for positive COVID-19 tests and 96% for negative tests.

New markers for heart attacks

A new study identifies markers in the blood of heart attack patients that distinguishes them from patients suffering chest pain with other causes.

Come together

After one of the most challenging years in our professional history, we’re looking forward to celebrating Biomedical Science Day 2021.

Top